查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853704

非PVC輸液袋市場：按材料、產品類型、應用、最終用戶和產能分類－2025-2032年全球預測

Non-PVC IV bags Market by Material, Product Type, Application, End User, Capacity - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，非 PVC 輸液袋市場將成長至 64.9 億美元，複合年成長率為 13.08%。

關鍵市場統計數據
基準年 2024 24.2億美元
預計年份：2025年 27.4億美元
預測年份 2032 64.9億美元
複合年成長率 (%) 13.08%

非PVC輸液袋綜合框架重點在於材料創新、監管促進因素和影響採購和臨床應用的永續力量。

非聚氯乙烯（PVC）輸液袋的出現，融合了材料科學創新、臨床安全考量和永續性需求。新型彈性體和聚合物（例如聚烯）的開發，使得軟性醫用輸液袋的研發成為可能，避免了傳統PVC材質中塑化劑的風險。這一發展趨勢既反映了臨床醫生的偏好，也反映了醫療機構採購方式的轉變，即傾向於選擇能夠降低可溶性物質滲出和潛在長期患者暴露風險的醫療器材。

除了臨床安全性之外，環境和循環利用方面的考慮也推動了非PVC輸液袋在配方和採購框架中的應用。醫院和醫療保健系統越來越傾向於選擇環境友善的產品特性，例如端到端可追溯性、減少鄰苯二甲酸酯的使用以及提高可回收性。因此，製造商正在調整材料和生產流程，優先考慮封閉式流程、易於滅菌以及與現有輸液系統的兼容性。

監管機構的嚴格審查以及可萃取物和可浸出物測試標準的不斷完善，也使得不含聚氯乙烯（PVC）的解決方案備受關注。監管機構和標準制定機構持續改進對材料表徵、生物相容性和標籤的要求。這要求新參與企業和現有供應商在其產品開發生命週期中納入完善的測試通訊協定，以促進及時核准並被醫院採用。

總而言之，輸液袋中PVC材質的淘汰不僅意味著原料的改變，更代表系統性的轉變，涵蓋供應鏈重組、臨床醫生培訓和生命週期管理等各個面向。這些動態為透過設計、安全溝通和永續性認證實現差異化提供了機遇，同時也帶來了採購、檢驗和監管方面的複雜性。

聚合物科學創新、供應鏈韌性、不斷變化的採購方式以及監管預期如何重新定義非PVC輸液袋的競爭優勢

非PVC輸液袋市場格局正因技術和結構趨勢的融合而重塑，這些趨勢正在改變競爭動態和價值鏈。材料科學的突破性進展拓展了聚合物的選擇範圍，以滿足無菌性、柔韌性和貼合性要求，使製造商能夠重新設計外形規格，並整合符合現代臨床規範的藥物相容性資訊。同時，醫療保健系統日益成長的環保期望也預示著對生命週期環境足跡更低的產品需求正在加速成長。

同時，採購和供應鏈策略也不斷演變，這主要得益於近期全球動盪帶來的經驗教訓。醫療服務提供者正在實現供應商多元化，增強庫存韌性，並重視那些能夠展現透明度、提供切實可行的替代採購方案以及快速擴大規模的供應商。這種採購方式的轉變與製造和物流領域的數位轉型相輔相成，自動化、品質源自於設計和可追溯性工具正成為企業脫穎而出的關鍵因素。

臨床實務也不斷調整，臨床醫師和藥局團隊在產品選擇初期就展開合作，以確保產品與輸液幫浦、過濾器和床邊工作流程的兼容性。醫院處方集委員會除了傳統的療效和成本標準外，還納入了永續性和病人安全標準，從而提升了非PVC替代藥物的可靠臨床證據和真實世界表現數據的重要性。

最後，監管協調和標準制定機構越來越重視可萃取物、可浸出物、生物相容性和標籤清晰度。這些監管利好因素迫使製造商投入更多資源進行更嚴格的材料表徵，並記錄其生命週期影響。這種變革性轉變既是挑戰，也是機遇，能夠將材料性能、供應鏈韌性和可證實的臨床價值相結合的公司的發展方向。

評估關稅政策的變化如何促使非PVC輸液袋產業進行供應鏈重組、材料採購調整和採購優先重新調整。

影響醫療設備原料和包裝的關稅政策調整，為非PVC輸液袋製造商及其下游醫療保健客戶的採購計算引入了新的變數。某些聚合物進口和組件關稅的提高可能會增加部分原料的到岸成本，促使製造商重新評估供應商的地域分佈和材料替代策略。這加速了製造商尋求本地生產或替代供應商的努力，以確保產品品質穩定，同時減輕關稅的影響。

除了對投入成本的直接影響外，關稅波動也會影響庫存管理。製造商和經銷商已採取應對措施，例如延長前置作業時間緩衝期、增加戰略安全庫存以及簽訂多年期契約，以確保供應的連續性。雖然這些措施有助於降低風險，但可能加劇資本和營運成本緊張，並可能導致供應商關係轉向那些物流可預測性更高、供應鏈符合關稅規定的供應商。

關稅也影響醫療服務提供者的採購行為。集團採購組織和醫院供應團隊正在更密切地審查總體擁有成本和供應商的抗風險能力，並將運輸的複雜性、海關程序以及成本可能出現的突發波動考慮在內。這種審查通常有利於那些採購流程透明、擁有區域性製造地或附加價值服務以減少採購摩擦的供應商。

最後，關稅主導的環境正在加速製造商和聚合物供應商之間的合作，以開發國內採購的等級產品和免稅材料管道。此類合作旨在維持產品性能的同時，降低受貿易政策波動的影響。因此，積極重新設計供應鏈或確保獲得不受關稅影響的採購管道的公司，能夠更好地為臨床客戶提供穩定的價格和可靠的前置作業時間。

詳細的細分分析揭示了材料、產品結構、臨床用途、醫療環境和袋容量如何驅動採購和設計優先順序。

具體而言，乙烯醋酸乙烯（ EVA）、聚乙烯（PE）和聚丙烯（PP）各自具有不同的機械和化學性能，這些性能會影響材料的滲出性、耐滅菌性和可回收性。當柔韌性和透明度是優先考慮因素時，乙烯-乙烯醋酸乙烯通常是首選；而聚乙烯和聚丙烯在剛度、耐化學性和熱成型性能方面則各有側重，這些性能會影響密封性和灌裝線的完整性。了解這些材料之間的權衡對於使產品設計與最終用戶的操作和臨床工作流程相匹配至關重要。

在臨床給藥場景中，產品架構至關重要。非PVC材質的輸液器有單腔和多腔兩種配置，多腔輸液器可細分為雙腔和三腔兩種形式，以滿足複雜治療方法的穩定性和混合需求。單腔輸液器滿足常規輸注需求，而雙腔和三腔多腔輸液器則可實現按需混合，從而減少床邊混合，提高多組分療法的穩定性。這些差異會影響藥局配藥環境中的採購決策，並進而影響整個醫療機構的庫存策略。

基於應用領域的細分反映了產品屬性如何契合臨床應用場景，例如血液採集、透析、輸液治療和營養治療。在血液採集和透析領域，機械強度、抗凝血劑相容性和經認證的無菌性是關鍵考慮因素。輸液治療要求與輸液幫浦和管路組件的精確相容性，而營養治療則要求輸液袋材料和介面設計能夠支援長時間留置給藥、顆粒物控制以及與腸外營養製劑的兼容性。每種應用都對製造商提出了特定的驗證和標籤檢視要求。

終端用戶環境影響門診中心、診所、居家照護和醫院等不同場所的產品採納動態。門診中心和診所優先考慮易用性、高效儲存和快速週轉；居家照護優先考慮便攜性、病人安全和易於管理；醫院則要求產品與各種臨床設備廣泛兼容，並嚴格遵守感染控制通訊協定。這些不同的優先事項需要差異化的產品系列和不同的服務模式。

根據容量大小，輸液袋分為 500ml 以下、500ml 至 1000ml 以及 1000ml 以上三個級別，容量分類與治療強度和工作流程設計相符。小容量輸液袋常用於大劑量投藥和兒科給藥，中等容量輸液袋用於常規和一般輸注，大容量輸液袋則滿足高容量需求和特殊應用。容量選擇會影響包裝、運輸效率和儲存空間，進而影響臨床現場的採購和庫存最佳化。

區域戰略觀點，詳細闡述美洲、中東和非洲以及亞太地區的採購文化、監管嚴格程度和製造佈局的差異。

在美洲，需求促進因素主要來自臨床安全法規（鼓勵使用非PVC替代品）和機構永續性計畫。區域製造能力和完善的分銷網路支援產品快速供應，而採購機構則注重成本控制並關注供應商的韌性。因此，能夠提供透明供應鏈和生命週期影響數據的製造商更有可能吸引該地區的買家。

歐洲、中東和非洲地區（EMEA）的特點是法規環境各異，且高度關注環境和公共衛生問題。歐洲市場尤其重視嚴格的萃取物和浸出物測試、全面的材料文件以及環境聲明。此外，醫療保健採購框架強調循環經濟計劃和生產者延伸責任理念，這些因素正在影響全部區域產品的採用時間表和設計選擇。

亞太地區呈現出充滿活力的格局，醫療基礎設施的快速發展與多元化的監管環境和區域特有的供應動態並存。該地區多個國家優先發展國內製造業，以促進關鍵醫療耗材產能的擴張。同時，跨境貿易和區域供應夥伴關係在平衡激增的需求與產能方面發揮關鍵作用。能夠適應當地臨床實踐並符合區域監管要求的製造商往往能夠獲得更高的市場滲透率。

在所有地區，我們都看到環境期望不斷提高、材料安全測試日益嚴格以及供應鏈透明度日益增強的趨勢。能夠根據當地監管態度和採購文化調整提案價值主張的製造商和經銷商，將更有利於支持醫療保健機構採用相關技術並建立長期夥伴關係。

分析產品檢驗、策略夥伴關係、製造佈局最佳化和附加價值服務如何重新定義製造商之間的競爭定位。

非PVC輸液袋市場的競爭力取決於產品創新、供應鏈可靠性以及臨床和環境可靠性的證明能力。領先的製造商投資於端到端的驗證項目，以記錄可萃取物、可萃取物和生物相容性，同時透過自動化和品質源自於設計（QbD）方法提高生產效率。這些投資加快了新配方的上市速度，並提高了企業在醫院採購委員會的信譽。

對於希望加快材料資格確認和核准申報的企業而言，聚合物供應商、契約製造和臨床研究機構之間的策略夥伴關係正變得越來越普遍。契約製造關係能夠靈活地擴大生產規模，而與聚合物創新者的合作則有可能創造出兼顧性能和可回收性的獨特配方。此類合作通常能夠創造差異化的價值提案，將材料科學專業知識與臨床檢驗能力結合。

服務差異化正變得日益重要，多家公司提供包含設備相容性測試、供應連續性保障和永續性文件在內的捆綁式解決方案。此類附加價值服務可減少採購摩擦，並使醫療系統的運作實際情況與製造商的產品相符。此外，最佳化生產佈局和近岸舉措也是縮短前置作業時間和降低政策主導貿易中斷風險的常用策略。

併購和授權協議也在影響競爭格局，因為企業都在尋求透過技術能力和地域覆蓋來完善其產品系列。最終，企業能否在這個領域取得成功，取決於它們能否使產品性能與監管合規性保持一致，提供透明的供應保障，並向機構投資者展示可衡量的永續性效益。

針對製造商和供應商的具體、優先的策略行動，旨在加強產品檢驗、供應鏈彈性、永續性證據和臨床整合。

在產品開發早期階段，應優先進行材料表徵以及嚴格的萃取物和浸出物測試，以縮短法規核准流程並增強臨床信心。儘早投入全面的生物相容性和穩定性研究，有助於向臨床醫生和採購團隊清晰傳達安全性訊息。同時，設計選擇應與典型的臨床工作流程相符，以最大限度地減少與輸液幫浦、輸液管路和床邊操作的整合摩擦。

透過供應商地理多元化、尋找關鍵聚合物的二級資訊來源以及探索區域生產中心來增強供應鏈韌性，從而降低關稅和物流波動的影響。考慮與主要聚合物供應商建立長期合作關係，並將需求感知分析與戰略庫存緩衝相結合，以平衡成本和供應。供應鏈的透明度將成為重視可靠性的機構投資者的重要考量。

透過服務和永續性實現差異化。除了產品本身，還要提供生命週期評估、回收途徑和報廢產品管理策略。將技術性能與檢驗的環境資格相結合，以增強對採購團隊的吸引力，因為他們將永續性納入選擇標準。為了減少新用戶引入的阻力，提供技術支援包，以促進臨床醫生培訓、床邊應用和藥房檢驗。

投資於模組化產品平台，這些平台可以快速配置為單腔、多腔以及各種容量，以滿足不同的臨床需求。模組化平台可以降低模具成本，並加快對不斷變化的應用需求的應對力。除了產品模組化之外，還應提供針對性的臨床證據，證明其在血液採集、透析、輸液治療和營養治療等場景中的安全有效應用。

最後，積極主動地與監管機構和標準制定機構溝通，以便及時了解材料測試、標籤和環境報告方面不斷變化的要求。與監管機構互動不僅可以降低核准的不確定性，還能將貴公司打造成為醫療保健系統和採購聯盟值得信賴的合作夥伴。

對用於檢驗調查結果、綜合專家意見並得出可操作戰略建議的定性和分析方法進行透明的描述

該分析整合了來自專家訪談、技術白皮書、監管指導文件以及採購和臨床相關人員的營運見解等證據，以確保研究結果基於實際決策。我們與材料科學家、生產負責人、藥屋主任和採購專業人員等各領域人士進行了訪談，以收集他們對材料性能、供應鏈限制和臨床應用障礙的不同觀點。

二級資訊來源包括同行評審的關於聚合物在醫療設備中性能的文獻、公開的關於可萃取物和可浸出物的監管指南，以及一系列有助於考慮可用性和相容性的臨床實踐資源。透過將專家證詞與技術文獻和監管出版物進行交叉比對，實現了資料三角驗證，以檢驗有關材料特性、滅菌相容性和臨床應用案例的說法。

分析方法包括對專家訪談進行定性編碼以識別反覆出現的主題，情境分析以評估關稅和供應鏈的影響，以及跨區域比較以突出監管和採購方面的差異。在適當情況下，還使用了風險矩陣和決策框架，以可行性、影響和實施時間等標準，為製造商和醫療系統採購人員確定策略行動的優先順序。

此方法強調質性研究的嚴謹性和三角驗證，同時兼顧研究結果的臨床實用性，並持續對照監管要求核查，以確保建議切實可行，並符合相關人員的期望。此方法透過記錄訪談參數、資訊來源類型以及用於得出研究結論的分析技術，確保研究結果的可重複性。

最終結果表明，材料檢驗、供應鏈韌性、監管合規和臨床整合對於無PVC靜脈輸液的長期成功至關重要。

推廣使用不含聚氯乙烯（PVC）的輸液袋反映了更廣泛的醫療保健趨勢，即優先考慮患者安全、環境保護和供應鏈韌性。材料創新、對可萃取物和可浸出物監管環境的日益關注，以及納入永續性標準的醫療保健採購框架，共同構成了一個要求產品在技術性能之外，還必須具備可驗證的安全性和生命週期可靠性的市場環境。那些能夠使其產品設計、測試和供應策略與這些要求相契合的企業，將更有利於贏得醫療機構的信任。

對供應鏈架構和關稅韌性的策略關注將繼續影響採購動態，促使製造商尋求本地化生產、實現供應商多元化並提供透明的採購文件。同時，透過臨床證據實現的產品差異化、與現有輸液生態系統的兼容性以及配套服務將決定產品在醫院、診所、門診中心和居家照護機構的推廣速度。

歸根結底，從PVC過渡到其他材料是一項多方面的挑戰，需要研發、監管、生產和商業團隊的協調行動。積極主動地應對材料檢驗、監管要求和客戶營運需求的企業，將能夠把這些挑戰轉化為競爭優勢，從而支持更安全的患者治療效果和永續的醫療保健服務。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 逐步過渡到環保型、生物基、非PVC材料，以減少醫院塑膠廢棄物。
  • 推出雙腔無PVC輸液袋，可提高藥物穩定性和安全性。
  • 新生兒和小兒科護理中擴大採用不含鄰苯二甲酸二辛酯（DEHP）和非聚氯乙烯（PVC）的輸液。
  • 投資研發先進的塑化劑替代品，以提高非PVC袋的柔韌性
  • 日益嚴格的法規要求使用不含鄰苯二甲酸酯的靜脈輸液容器，這推動了產品創新。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 非PVC輸液袋市場（依材料分類）

  • 乙烯-醋酸乙烯酯
  • 聚乙烯
  • 聚丙烯

9. 非PVC輸液袋市場（依產品類型分類）

  • 多重腔體
    • 三間房
    • 兩間房
  • 單人房

第10章 非PVC輸液袋市場依應用領域分類

  • 血液收集
  • 透析
  • 靜脈注射療法
  • 營養療法

第11章 非PVC輸液袋市場（依最終用戶分類）

  • 門診中心
  • 診所
  • 家庭環境
  • 醫院

第12章 非PVC輸液袋市場（以銷量計）

  • 500～1000ml
  • 1000毫升或更多
  • 少於500毫升

第13章 各地區非PVC輸液袋市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 非PVC輸液袋市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國非PVC輸液袋市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • BAXTER INTERNATIONAL INC.
    • FRESENIUS KABI AG
    • B. BRAUN MELSUNGEN AG
    • ICU MEDICAL, INC.
    • NIPRO CORPORATION
    • TERUMO CORPORATION
    • POLY MEDICURE LIMITED
    • WUJIANG DONGLI MEDICAL PRODUCTS CO., LTD.
    • PROTEK MEDICAL（SHANGHAI）CO., LTD.
    • CHONGQING KANGJIE MEDICAL INSTRUMENTS CO., LTD.
Product Code: MRR-8C74ADFC13EF

The Non-PVC IV bags Market is projected to grow by USD 6.49 billion at a CAGR of 13.08% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.42 billion
Estimated Year [2025] USD 2.74 billion
Forecast Year [2032] USD 6.49 billion
CAGR (%) 13.08%

A comprehensive framing of non-PVC intravenous bags highlighting material innovation, regulatory drivers, and sustainability forces shaping procurement and clinical adoption

Non-PVC intravenous containers are at the intersection of material science innovation, clinical safety priorities, and sustainability imperatives. Advances in polymers such as alternative elastomers and polyolefins have enabled the development of flexible, medical-grade bags that avoid the plasticizer-related risks associated with traditional PVC constructions. This evolution reflects both clinician preference and institutional procurement shifts toward devices that mitigate leachables and potential long-term patient exposure concerns.

Beyond clinical safety, environmental and circularity considerations are elevating non-PVC options in formulary deliberations and procurement frameworks. Hospitals and health systems increasingly demand end-to-end traceability and environmentally preferable product attributes, including reduced reliance on phthalates and improved recyclability. Consequently, manufacturers are responding with materials and manufacturing adjustments that prioritize closed-loop processes, ease of sterilization, and compatibility with existing infusion systems.

Regulatory scrutiny and evolving standards for extractables and leachables testing have also pushed non-PVC solutions into the spotlight. Regulatory agencies and standards bodies continue to refine expectations for material characterization, biocompatibility, and labeling. Thus, new entrants and established suppliers must integrate robust testing protocols into product development lifecycles to facilitate timely approvals and hospital adoption.

Taken together, the shift away from PVC for IV bags is not simply a change in raw materials; it represents a systemic reorientation involving supply chain reconfiguration, clinician education, and lifecycle management. These dynamics create opportunities for differentiation through design, safety communication, and sustainability credentials, while also introducing complexity in sourcing, validation, and regulatory pathways.

How innovation in polymer science, supply resilience, procurement evolution, and regulatory expectations are jointly redefining competitive advantage in non-PVC IV containers

The non-PVC IV bag landscape is being reshaped by converging technological and structural trends that are altering competitive dynamics and value chains. Material science breakthroughs have expanded the palette of viable polymers that meet sterility, flexibility, and compatibility requirements, enabling manufacturers to redesign form factors and integrate drug compatibility profiles that align with contemporary clinical protocols. Meanwhile, rising environmental expectations across healthcare systems are accelerating demand signals for products with lower lifecycle environmental footprints.

Concurrently, procurement and supply chain strategies are evolving in response to lessons learned from recent global disruptions. Healthcare providers are diversifying supplier bases, increasing inventory resilience, and placing higher value on suppliers that can demonstrate transparency, validated alternate sourcing, and quick scale-up capabilities. These procurement shifts are complemented by digital transformation in manufacturing and logistics, where automation, quality by design, and traceability tools are becoming differentiators.

Clinical practice is adapting as well, with clinicians and pharmacy teams collaborating earlier in product selection to ensure compatibility with infusion pumps, filters, and bedside workflows. Hospital formulary committees are incorporating sustainability and patient-safety criteria alongside traditional efficacy and cost considerations, which elevates the importance of robust clinical evidence and real-world performance data for non-PVC alternatives.

Finally, regulatory harmonization and standard-setting bodies are increasingly focused on extractables and leachables, biocompatibility, and labeling clarity. These regulatory drivers are forcing manufacturers to invest in more rigorous material characterization and to document lifecycle impacts. Together, these transformative shifts are creating both barriers and avenues for companies that can align material performance, supply chain resilience, and demonstrable clinical value.

Evaluating how shifts in tariff policy are prompting supply chain reconfiguration, material sourcing adaptations, and procurement reprioritization across the non-PVC IV bag sector

Tariff policy adjustments affecting medical device inputs and packaging have introduced a new variable into the sourcing calculus for non-PVC IV bag manufacturers and their downstream healthcare customers. Increased duties on certain polymer imports and components can raise the landed cost of some raw materials, prompting manufacturers to reevaluate supplier geographies and material substitution strategies. This has led to accelerated efforts to localize production or qualify alternative upstream suppliers that can provide consistent quality while mitigating tariff exposure.

In addition to direct input-cost effects, tariff changes influence inventory management practices. Manufacturers and distributors have adapted by lengthening lead-time buffers, increasing strategic safety stocks, and negotiating multi-year contracts to lock in supply continuity. These responses, while prudent for risk mitigation, can introduce capital and working-capital pressures and may shift supplier relationships toward those with better logistical predictability and tariff-compliant supply chains.

Tariffs also affect procurement behavior at the healthcare provider level. Group purchasing organizations and hospital supply teams are scrutinizing total cost of ownership and supplier resilience more closely, factoring in transport complexity, customs procedures, and potential for sudden cost volatility. Such scrutiny often favors suppliers with transparent sourcing, regional manufacturing presence, or value-added services that reduce procurement friction.

Finally, the tariff-driven landscape fosters accelerated collaborations between manufacturers and polymer producers to develop domestically-sourced grades or tariff-exempt material pathways. These collaborations aim to preserve product performance while alleviating exposure to trade policy fluctuations. Consequently, firms that proactively redesign supply chains or secure tariff-resilient sourcing pathways are better positioned to offer stable pricing and reliable lead times to clinical customers.

In-depth segmentation analysis revealing how materials, product architectures, clinical applications, care settings, and bag capacities drive procurement and design priorities

Material selection drives clinical compatibility and manufacturing processes, particularly where Ethylene Vinyl Acetate, Polyethylene, and Polypropylene each present distinct mechanical and chemical performance profiles that influence leachables, sterilization tolerance, and recyclability. Ethylene Vinyl Acetate is often favored where flexibility and clarity are prioritized, while Polyethylene and Polypropylene provide different balances of rigidity, chemical resistance, and thermoforming characteristics that affect sealing and fill-line integrity. Understanding these material trade-offs is essential for aligning product design to end-user handling and clinical workflows.

Product architecture matters in clinical delivery scenarios, with non-PVC solutions available as single chamber or multi chamber configurations and multi chamber variants further differentiated into two-chamber and three-chamber formats to support stability and admixture requirements for complex therapies. Single chamber designs are straightforward for routine infusion needs, whereas two-chamber and three-chamber multi chamber formats enable on-demand mixing, reduced compounding at the bedside, and improved stability for multi-component therapies. These distinctions inform procurement decisions in pharmacy compounding environments and influence inventory strategies across care settings.

Application-based segmentation reflects how product attributes are matched to clinical use cases such as blood collection, dialysis, infusion therapy, and nutrition therapy. In blood collection and dialysis, mechanical robustness, anticoagulant compatibility, and certified sterility are primary concerns. Infusion therapy demands precise compatibility with pumps and tubing sets, while nutrition therapy requires bag materials and port designs that support long-dwell administration, particulate control, and compatibility with parenteral nutrition formulations. Each application imposes specific validation and labeling expectations that manufacturers must meet.

End-user contexts shape uptake dynamics, spanning ambulatory centers, clinics, home care, and hospitals. Product selection criteria vary across these settings: ambulatory centers and clinics emphasize ease of use, storage efficiency, and rapid turnover; home care prioritizes portability, patient safety, and simplified administration; hospitals require broad compatibility with diverse clinical devices and strict compliance with infection-control protocols. These divergent priorities necessitate differentiated product portfolios and tailored service models.

Capacity segmentation, covering less than 500 milliliter bags, 500 to 1000 milliliter ranges, and greater than 1000 milliliter capacities, aligns with therapy intensity and workflow design. Smaller volumes are frequently used for bolus or pediatric administration, mid-range capacities support routine infusion and common fluid administration, and larger capacities cater to high-volume needs or specialty applications. Capacity decisions influence packaging, transport efficiency, and storage footprint, which in turn affect procurement and inventory optimization across clinical settings.

Regional strategic perspectives detailing how procurement cultures, regulatory rigor, and manufacturing footprints vary across the Americas, Europe Middle East & Africa, and Asia-Pacific

In the Americas, demand drivers are shaped by a combination of clinical safety mandates and institutional sustainability programs that incentivize non-PVC alternatives. Regional manufacturing capacity and a well-developed distribution network support rapid product availability, yet procurement organizations remain cost-sensitive and attentive to supplier resilience. Consequently, manufacturers that offer transparent supply chains and lifecycle-impact data often find receptive buyers in this region.

The Europe, Middle East & Africa region is characterized by heterogenous regulatory environments and an elevated focus on environmental and public-health imperatives. European markets in particular emphasize stringent extractables and leachables testing, comprehensive material documentation, and environmental declarations. Medical procurement frameworks also give weight to circular-economy initiatives and extended producer responsibility concepts, which influence adoption timelines and product design choices across the region.

Asia-Pacific presents a varied landscape where rapid healthcare infrastructure development coexists with diverse regulatory regimes and localized supply dynamics. Several countries in the region prioritize domestic manufacturing and are fostering capacity expansion for critical medical consumables. At the same time, cross-border trade and regional supply partnerships play a substantial role in balancing demand surges with production capabilities. Manufacturers that can adapt configurations to local clinical practices and align with regional regulatory requirements tend to achieve stronger market penetration.

Across all regions, convergence is observable in heightened expectations for environmental stewardship, expanded testing for material safety, and supply chain transparency. Manufacturers and distributors that can tailor value propositions to each region's regulatory posture and procurement culture will be better positioned to support adoption and long-term partnerships with healthcare providers.

Analysis of how product validation, strategic partnerships, manufacturing footprint optimization, and value-added services are redefining competitive positioning among manufacturers

Competitive dynamics in the non-PVC IV bag sector are defined by a blend of product innovation, supply chain reliability, and the ability to demonstrate clinical and environmental credentials. Leading manufacturers are investing in end-to-end validation programs that document extractables, leachables, and biocompatibility, while also pursuing manufacturing efficiency gains through automation and quality-by-design methodologies. These investments reduce time-to-market for new formulations and bolster confidence among hospital procurement committees.

Strategic partnerships between polymer suppliers, contract manufacturers, and clinical research organizations are becoming more common as firms seek to accelerate material qualification and regulatory submissions. Contract manufacturing relationships enable scale-up flexibility, while collaborations with polymer innovators can yield proprietary formulations that balance performance with recyclability. Such alliances often create differentiated value propositions that combine material science expertise with clinical validation capabilities.

Service differentiation is increasingly significant, with several companies offering bundled solutions that include device compatibility testing, supply continuity guarantees, and sustainability documentation. These value-added services reduce procurement friction and align manufacturer offerings with the operational realities of health systems. Additionally, manufacturing footprint optimization and nearshoring initiatives are common tactics to reduce lead times and limit exposure to policy-driven trade disruptions.

Mergers, acquisitions, and licensing arrangements are also influencing competitive landscapes, as firms seek to complement product portfolios with technical capabilities or geographic reach. Ultimately, corporate success in this sector depends on the ability to align product performance with regulatory compliance, provide transparent supply assurances, and articulate measurable sustainability benefits to institutional buyers.

Concrete and prioritized strategic actions for manufacturers and suppliers to enhance product validation, supply resilience, sustainability credentials, and clinical integration

Prioritize material characterization and rigorous extractables and leachables testing early in product development to shorten regulatory pathways and build clinical confidence. Early investment in comprehensive biocompatibility and stability studies enables clearer safety messaging to clinicians and procurement teams. Simultaneously, align design choices with typical clinical workflows to minimize integration friction with infusion pumps, tubing sets, and bedside procedures.

Strengthen supply chain resilience by diversifying supplier geographies, qualifying secondary sources for critical polymer inputs, and exploring regional production hubs to mitigate tariff and logistics volatility. Establish long-term relationships with key polymer suppliers and consider strategic inventory buffers combined with demand-sensing analytics to balance cost and availability. Transparency across the supply chain will be a differentiator for institutional purchasers focused on reliability.

Differentiate through service and sustainability: provide lifecycle assessments, recyclability pathways, and end-of-life management strategies alongside product offerings. Coupling technical performance with verified environmental credentials will enhance appeal to procurement teams that incorporate sustainability into selection criteria. Offer technical support packages that facilitate clinician training, bedside adoption, and pharmacy validation to reduce onboarding friction.

Invest in modular product platforms that allow for rapid configuration of single chamber and multi chamber formats and varied capacities to meet diverse clinical needs. Modular platforms reduce tooling costs and accelerate responsiveness to shifting application demands. Complement product modularity with targeted clinical evidence generation that demonstrates safe, effective use across blood collection, dialysis, infusion therapy, and nutrition therapy scenarios.

Finally, engage proactively with regulatory bodies and standards organizations to stay ahead of evolving expectations on material testing, labeling, and environmental reporting. Regulatory engagement not only reduces approval uncertainty but also positions companies as trusted partners to health systems and procurement consortia.

Transparent description of the qualitative and analytical approaches used to validate findings, synthesize expert input, and derive practical strategic recommendations

This analysis synthesizes evidence from primary expert interviews, technical whitepapers, regulatory guidance documents, and operational insights from procurement and clinical stakeholders to ensure findings are grounded in real-world decision contexts. Primary interviews were conducted with a cross-section of materials scientists, manufacturing leaders, pharmacy directors, and procurement professionals to capture diverse perspectives on material performance, supply chain constraints, and clinical adoption barriers.

Secondary sources include peer-reviewed literature on polymer performance in medical devices, publicly available regulatory guidance on extractables and leachables, and aggregated clinical practice resources that inform usability and compatibility considerations. Data triangulation was achieved by cross-referencing expert testimony with technical literature and regulatory communications to validate assertions about material properties, sterilization compatibility, and clinical use cases.

Analytical techniques included qualitative coding of expert interviews to identify recurring themes, scenario analysis to assess tariff and supply-chain impacts, and cross-regional comparison to elucidate regulatory and procurement differences. Where appropriate, risk matrices and decision frameworks were employed to prioritize strategic actions for manufacturers and health-system purchasers, focusing on feasibility, impact, and time-to-implement criteria.

While this methodology emphasizes qualitative rigor and triangulation, findings were continuously checked against clinical usability considerations and regulatory requirements to ensure recommendations are both actionable and aligned with stakeholder expectations. The methodology supports reproducibility by documenting interview parameters, source types, and analytic approaches used to derive the insights presented.

Final synthesis highlighting why material validation, supply chain resilience, regulatory alignment, and clinical integration are critical to long-term success in non-PVC IV solutions

The transition toward non-PVC IV bags reflects broader healthcare trends that prioritize patient safety, environmental responsibility, and supply chain resilience. Material innovation, regulatory emphasis on extractables and leachables, and healthcare procurement frameworks that incorporate sustainability criteria collectively create a landscape in which technical performance must be matched by demonstrable safety and lifecycle credentials. Organizations that align product design, testing, and supply strategies with these imperatives will be better positioned to win institutional trust.

Strategic attention to supply chain architecture and tariff resilience will continue to influence procurement dynamics, prompting manufacturers to pursue regional production, secure diversified suppliers, and provide transparent sourcing documentation. At the same time, product differentiation through clinical evidence, compatibility with existing infusion ecosystems, and support services will determine the pace of adoption across hospitals, clinics, ambulatory centers, and home-care environments.

Ultimately, the shift away from PVC is a multi-dimensional challenge that requires coordinated action across R&D, regulatory affairs, manufacturing, and commercial teams. Companies that proactively address material validation, regulatory expectations, and customer operational needs can convert these challenges into competitive advantages, supporting safer patient outcomes and more sustainable healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Shift toward eco-friendly biobased non-PVC materials reducing hospital plastic waste
  • 5.2. Emergence of dual-chamber non-PVC IV bags for enhanced drug stability and safety
  • 5.3. Rising adoption of DEHP-free non-PVC infusion solutions in neonatal and pediatric care
  • 5.4. Investment in advanced plasticizer alternatives improving non-PVC bag flexibility
  • 5.5. Regulatory push for phthalate-free intravenous containers driving product innovation

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-PVC IV bags Market, by Material

  • 8.1. Ethylene Vinyl Acetate
  • 8.2. Polyethylene
  • 8.3. Polypropylene

9. Non-PVC IV bags Market, by Product Type

  • 9.1. Multi Chamber
    • 9.1.1. Three Chamber
    • 9.1.2. Two Chamber
  • 9.2. Single Chamber

10. Non-PVC IV bags Market, by Application

  • 10.1. Blood Collection
  • 10.2. Dialysis
  • 10.3. Infusion Therapy
  • 10.4. Nutrition Therapy

11. Non-PVC IV bags Market, by End User

  • 11.1. Ambulatory Centers
  • 11.2. Clinics
  • 11.3. Home Care
  • 11.4. Hospitals

12. Non-PVC IV bags Market, by Capacity

  • 12.1. 500 To 1000 Ml
  • 12.2. Greater Than 1000 Ml
  • 12.3. Less Than 500 Ml

13. Non-PVC IV bags Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Non-PVC IV bags Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Non-PVC IV bags Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. BAXTER INTERNATIONAL INC.
    • 16.3.2. FRESENIUS KABI AG
    • 16.3.3. B. BRAUN MELSUNGEN AG
    • 16.3.4. ICU MEDICAL, INC.
    • 16.3.5. NIPRO CORPORATION
    • 16.3.6. TERUMO CORPORATION
    • 16.3.7. POLY MEDICURE LIMITED
    • 16.3.8. WUJIANG DONGLI MEDICAL PRODUCTS CO., LTD.
    • 16.3.9. PROTEK MEDICAL (SHANGHAI) CO., LTD.
    • 16.3.10. CHONGQING KANGJIE MEDICAL INSTRUMENTS CO., LTD.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-PVC IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NON-PVC IV BAGS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NON-PVC IV BAGS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NON-PVC IV BAGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NON-PVC IV BAGS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NON-PVC IV BAGS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY THREE CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY THREE CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY THREE CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY THREE CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY THREE CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY THREE CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY TWO CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY TWO CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY TWO CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY TWO CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY TWO CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY TWO CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY DIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY DIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY DIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY DIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY DIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY INFUSION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY INFUSION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY INFUSION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY INFUSION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY INFUSION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY INFUSION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY NUTRITION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY NUTRITION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY NUTRITION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY NUTRITION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY NUTRITION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY NUTRITION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY AMBULATORY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY AMBULATORY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY AMBULATORY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY AMBULATORY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY 500 TO 1000 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY 500 TO 1000 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY 500 TO 1000 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY 500 TO 1000 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY 500 TO 1000 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY 500 TO 1000 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GREATER THAN 1000 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GREATER THAN 1000 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GREATER THAN 1000 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GREATER THAN 1000 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GREATER THAN 1000 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GREATER THAN 1000 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY LESS THAN 500 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY LESS THAN 500 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY LESS THAN 500 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY LESS THAN 500 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY LESS THAN 500 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY LESS THAN 500 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 200. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. AFRICA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 214. AFRICA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASEAN NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 244. ASEAN NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 245. ASEAN NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. ASEAN NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 255. GCC NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GCC NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GCC NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 258. GCC NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 259. GCC NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. GCC NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. GCC NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 262. GCC NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 263. GCC NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. GCC NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. GCC NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. GCC NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. GCC NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 268. GCC NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 283. BRICS NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. BRICS NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. BRICS NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 286. BRICS NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 287. BRICS NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. BRICS NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. BRICS NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 290. BRICS NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 291. BRICS NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. BRICS NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. BRICS NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. BRICS NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 297. G7 NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. G7 NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. G7 NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 300. G7 NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 301. G7 NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. G7 NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. G7 NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 304. G7 NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 305. G7 NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. G7 NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. G7 NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. G7 NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. G7 NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 310. G7 NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 311. NATO NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. NATO NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. NATO NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 314. NATO NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 315. NATO NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. NATO NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. NATO NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 318. NATO NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 319. NATO NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. NATO NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. NATO NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. NATO NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. NATO NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 324. NATO NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 325. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 328. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 329. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 333. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 335. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 336. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 337. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 338. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 339. CANADA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 340. CANADA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 341. CANADA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 342. CANADA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 343. CANADA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 344. CANADA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 345. CANADA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 346. CANADA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 347. CANADA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 348. CANADA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 349. CANADA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2024 (USD MILLION)
  • TABLE 350. CANADA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025-2032 (USD MILLION)
  • TABLE 351. MEXICO NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 352. MEXICO NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 353. MEXICO NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 354. MEXICO NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 355. MEXICO NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2024 (USD MILLION)
  • TABLE 356. MEXICO NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2025-2032 (USD MILLION)
  • TABLE 357. MEXICO NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 358. MEXICO NON-PVC I